|Bid||1.9400 x 2200|
|Ask||1.9500 x 36900|
|Day's Range||1.8600 - 2.0000|
|52 Week Range||0.8730 - 4.5600|
|Beta (5Y Monthly)||1.54|
|PE Ratio (TTM)||N/A|
|Earnings Date||Dec 14, 2021 - Dec 20, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.00|
Subscribe to Yahoo Finance Plus to view Fair Value for CTXRLearn more
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced that it will host a webcast on October 20, 2021 at 8:30 a.m. ET to discuss the Company's previously announced acquisition of I/ONTAK (E7777), an improved formulation of immunotoxin ONTAK®, which was previously approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma (CTCL).
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective products in adjunct cancer care, unique prescription products, and stem cell therapies, today announced that it will present at two investor conferences during the month of October 2021.
In this article, we discuss the 10 Reddit’s WallStreetBets stocks under $5. If you want to skip our detailed analysis of these stocks, go directly to the 5 Reddit’s WallStreetBets Stocks Under $5. Reddit forum WallStreetBets, with a user base of close to 11 million, is one of the hottest places in the finance world, […]